Mutual Fund Ownership
Ownership as on: Tue, 27 Feb, 2024

Bank of India Arbitrage Fund Regular Growth

NA
Other
Amount Invested (Cr.)0.73
% of AUM3.68%

Kotak Nifty Smallcap 50 Index Fund Regular Growth

NA
Index Funds
Amount Invested (Cr.)1.44
% of AUM2.79%

Aditya Birla Sun Life Nifty Smallcap 50 Index Fund Regular Growth

NA
Index Funds
Amount Invested (Cr.)5.28
% of AUM2.78%

Axis Nifty Smallcap 50 Index Fund Regular Growth

NA
Index Funds
Amount Invested (Cr.)6.69
% of AUM2.78%

JM Midcap Fund Regular Growth

NA
Equity
Amount Invested (Cr.)21.21
% of AUM2.71%

FAQs about Glenmark Pharmaceuticals share price

Glenmark Pharmaceuticals is trading at 926.45 as on Tue Feb 27 2024 07:08:08. This is -0.11% lower as compared to its previous closing price of 927.45.

The market capitalization of Glenmark Pharmaceuticals is 26143.32 Cr as on Tue Feb 27 2024 07:08:08.

The average broker rating on Glenmark Pharmaceuticals is Hold. The breakup of analyst rating is given below -

  • 1 analysts have given a strong buy rating
  • 2 analysts have given a buy rating
  • 6 analysts have given a hold rating
  • 3 analysts have given a sell rating
  • 0 analysts have given a strong sell rating

The 52 wk high for Glenmark Pharmaceuticals is 941.65 whereas the 52 wk low is 414.50

Glenmark Pharmaceuticals can be analyzed on the following key metrics -

  • TTM P/E: -
  • Sector P/E: 26.69
  • Dividend Yield: 0.27%
  • D/E ratio: -

Glenmark Pharmaceuticals reported a net profit of 297.25 Cr in 2023.

Recommended For You
Images
Trending Stocks
3,668.35+47.30(1.31%)
6,592.00-49.10 (-0.74%)